![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Olix - YouTube
Roblox videos... that's about it yes, my Roblox username is Olix (OlixYT, RealOlix, O1ix on some platforms) Business Enquiries: [email protected]
OliX and Lilly Enter Global Licensing Agreement for MASH and ...
1 day ago · SEONGNAM, South Korea, February 10, 2025--OliX and Eli Lilly announced a global licensing agreement, focusing on the development and commercialization of OliX’s OLX75016.
OliX and Lilly Enter Global Licensing Agreement for MASH and ...
2 days ago · OliX Pharmaceuticals is a clinical-stage pharmaceutical company developing therapeutics against a variety of disorders by down-regulating the expression of disease-causing genes based on its own ...
Olix, Eli Lilly to develop liver disease drug under $630 ...
Olix will use the upfront payment to complete a phase 1 clinical trial for its candidate OLX702A in Australia while Eli Lilly will work on further research, development and commercialization.
Lilly inks AdvanCell, OliX deals to expand in radiopharma, MASH
1 day ago · OliX selected the target after looking at genomic variants linked to MASH and other liver diseases. The Korean biotech is running a phase 1 trial of the candidate in healthy volunteers, and Lilly ...
OliX strikes $630 million deal with Lilly for obesity and ...
1 day ago · OliX Pharmaceuticals, a Korean biotech company specializing in RNA interference (RNAi) therapies, has signed an exclusive global licensing deal with Eli Lilly worth up to $630 million.The agreement, announced last Friday, grants Lilly the rights to develop and commercialize OLX75016, an experimental
Eli Lilly enters global license agreement with OliX for ...
2 days ago · OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly . This collaboration focuses on the development and commercialization of OliX’s OLX75016, a Phase 1 candidate primarily ...
OliX Pharmaceuticals signs 910 billion won deal with Eli ...
2 days ago · OliX Pharmaceuticals, a gene therapy developer, recorded a daily limit up on the 10th after news that it signed a global license agreement worth 910 billion won with Eli Lilly. /Courtesy of OliX ...
Eli Lilly acquires OliX Pharmaceuticals' OLX702A for ...
2 days ago · Eli Lilly acquires OliX Pharmaceuticals OLX702A for metabolic disease treatment Eli Lilly secures rights to new metabolic therapy OLX702A, promising advancements in liver disease treatment
Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty ...
1 day ago · OliX will receive an initial payment from Lilly to complete the Phase 1 clinical trial underway in Australia. In preclinical studies, OliX has demonstrated the efficacy of OLX75016 in addressing ...
- Some results have been removed